Microdose Study of 14C‐Acetaminophen With Accelerator Mass Spectrometry to Examine Pharmacokinetics of Parent Drug and Metabolites in Healthy Subjects
暂无分享,去创建一个
H. Kusuhara | Y. Sugiyama | H Kusuhara | Y Sugiyama | T Ikeda | Z Tozuka | K Nozawa | Y Hamabe | I Ikushima | I. Ikushima | T. Ikeda | Y. Hamabe | K. Nozawa | Z. Tozuka
[1] Laura P James,et al. Acetaminophen-induced hepatotoxicity. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[2] D. Thompson,et al. Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity , 2005, Critical reviews in toxicology.
[3] F. Kamali. The effect of probenecid on paracetamol metabolism and pharmacokinetics , 2004, European Journal of Clinical Pharmacology.
[4] E. Matsumoto,et al. A Batch Preparation Method for Graphite Targets With Low Background for AMS 14C Measurements , 1993, Radiocarbon.
[5] Yuichi Sugiyama,et al. Drug-Drug Interactions Involving the Membrane Transport Process , 2001 .
[6] R. Weinshilboum,et al. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. , 2008, Birth defects research. Part A, Clinical and molecular teratology.
[7] H. Kusuhara,et al. Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices , 2007, Journal of Pharmacology and Experimental Therapeutics.
[8] Y Kumagai,et al. Microdose study of a P‐glycoprotein substrate, fexofenadine, using a non‐radioisotope‐labelled drug and LC/MS/MS , 2010, Journal of clinical pharmacy and therapeutics.
[9] R C Garner,et al. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[10] Graham Lappin,et al. Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics. , 2008, Expert opinion on drug metabolism & toxicology.
[11] Yuichi Sugiyama,et al. Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] D. Greenblatt,et al. Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid , 1993, Biopharmaceutics & drug disposition.
[13] Yuichi Sugiyama,et al. A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters , 2005, Journal of Pharmacology and Experimental Therapeutics.
[14] B. Beermann,et al. Non-linear elimination and protein binding of probenecid , 2004, European Journal of Clinical Pharmacology.
[15] L F Prescott,et al. Kinetics and metabolism of paracetamol and phenacetin. , 1980, British journal of clinical pharmacology.
[16] R. C. Garner,et al. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts. , 2000, Journal of pharmaceutical and biomedical analysis.
[17] K. Brouwer,et al. In vitro mechanisms of probenecid-associated alterations in acetaminophen glucuronide hepatic disposition. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[18] Toshio Nakamura,et al. A batch preparation method for graphite targets with low background for AMS (super 14) C measurements. , 1993 .
[19] Malcolm Rowland,et al. Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs , 2006, Clinical pharmacology and therapeutics.
[20] Hartmut Jaeschke,et al. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[21] L. Stevens,et al. Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics , 2008, Expert opinion on drug metabolism & toxicology.
[22] J. Clements,et al. Clinical Pharmacokinetics of Paracetamol , 1982, Clinical pharmacokinetics.
[23] G Levy,et al. Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. , 1984, Journal of pharmaceutical sciences.